An inhalable virus-like-particle vaccine against COVID-19

An inhalable virus-like-particle consisting of exosomes decorated with a recombinant SARS-Cov-2 receptor-binding domain is stable at room temperature and elicits systemic and mucosal immune responses in small animals.
Like

Share this post

Choose a social network to share with, or copy the shortened URL to share elsewhere

This is a representation of how your post may appear on social media. The actual post will vary between social networks

Please sign in or register for FREE

If you are a registered user on Research Communities by Springer Nature, please sign in

Subscribe to the Topic

Biotechnology
Life Sciences > Biological Sciences > Biotechnology